Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |